Introduction {#intro}
============

Metal allergy---defined as contact allergy to chromium, cobalt, or nickel---is prevalent in the general population ([@CIT0037]). Metal allergy typically develops early in life following prolonged or repeated skin contact with consumer items such as jewelry ([@CIT0022], [@CIT0017], [@CIT0035], [@CIT0040]), clothing fasteners ([@CIT0033], [@CIT0016]), cell phones ([@CIT0031], [@CIT0039]), and leather ([@CIT0011], [@CIT0015]). Upon repeated or prolonged cutaneous exposure, allergic individuals may develop allergic contact dermatitis, an itchy disorder characterized by erythema, papules, and vesicles.

With an increasingly ageing population, total hip arthroplasty (THA) is common. In the 1960s and 1970s, the initial prostheses used for THA were metal-on-metal but these were gradually abandoned, as they resulted in excessive release of cobalt and chromium into the blood, hair, and urine as well as metal sensitization and prosthesis loosening ([@CIT0004], [@CIT0003], [@CIT0007], [@CIT0010]). It remains unclear whether prosthesis loosening at the time was caused by metal allergy or vice versa ([@CIT0010], [@CIT0018]). During the 1970s and 1980s, the use of metal-on-polyethylene prostheses widely replaced the use of metal-on-metal prostheses. Metal allergy is rarely a problem with their use, and allergy does not appear to accompany or cause prosthesis failure ([@CIT0003], [@CIT0028], [@CIT0045], [@CIT0002]).

The popularity of metal-on-metal prostheses is once again increasing, as they have a lower volumetric wear rate, a high fracture toughness combined with the ability to use large femoral heads which may decrease the risk of postoperative instability ([@CIT0044], [@CIT0018]). Such prostheses typically consist of a forged, high-carbon cobalt-chromium-molybdenum material but many variations exist ([@CIT0019]). They produce a greater number of metal particles in nanometer size, which gives a high specific surface area ([@CIT0018]). Some authors have documented elevated serum and urine concentrations of cobalt and chromium ([@CIT0012], [@CIT0029], [@CIT0021], [@CIT0001], [@CIT0018]). The histopathological response is different from that of conventional metal-on-plastic bearings, as unusual lymphocytic aggregates may be observed in the periprosthetic tissues in patients with metal-on-metal articulations ([@CIT0005], [@CIT0047], [@CIT0018]). Also, clinically serious complications with aseptic lymphocytic vasculitic associated lesions (ALVAL) and pseudotumors have been reported ([@CIT0026], [@CIT0023]). Finally, T-helper cell 1 response is associated with metal induced reactivity ([@CIT0014]). To date, the long-term biological effect of elevated systemic metal concentrations is unknown, although it has been suggested that the prevalence of metal allergy could be higher among patients with implant failure ([@CIT0013], [@CIT0018]).

We had two aims in this study. Firstly, we wanted to investigate a possible association between metal allergy and THA. This was done by comparing the prevalence of metal allergy (defined as contact allergy to nickel, chromium, or cobalt) in patch-tested dermatitis patients with THA (cases) and in patch-tested dermatitis patients (controls) without any known THA. Secondly, we compared the prevalence (and cause) of revisions following THA in patch-tested dermatitis patients who had been treated at a tertiary dermatological referral center (cases) with the prevalence of "ordinary" patients who underwent THA but who were not registered in the patch-test database. This comparison was legitimate, since dermatitis patients have a high prevalence of metal allergy and since their immune system is considered to be highly active and to readily express delayed-type hypersensitivity reactions. Furthermore, metal allergies are likely to precede total hip arthroplasty in most patients, as sensitization usually occurs early in life. Thus, if metal allergy increases the risk of revision and prosthesis loosening, different frequencies of these parameters could possibly be identified in the two study groups.

Materials and methods {#s0002}
=====================

Study population {#s0003}
----------------

In Denmark, a unique civil registry (CVR) number is given to all Danish citizens at birth and also to immigrants when they become Danish residents. The CVR number encodes information about sex and date of birth, and is used for administrative purposes. In this study, we used the CVR number in a linkage study between two clinical databases. The first database contained patch-test results from all patients suspected to have allergic contact dermatitis (n = 18,794) between 1979 and 2007 at the Department of Dermato-allergology, Gentofte Hospital, Denmark. The second database, the Danish Hip Arthroplasty Registry (DHAR) at Aarhus University Hospital, contained information on patients with primary THA and revision performed in Denmark between 1996 and 2007. All 45 orthopedic departments in Denmark, including 5 departments in private hospitals, report to the DHAR ([@CIT0020]). The data registered, including pre-, peri- and postoperative data, were collected by the operating surgeon using standardized forms. 150 patients in the DHAR were not Danish citizens and were excluded from the analyses. Thus, the DHAR contained detailed information on 90,697 hip arthroplasty operations and revisions based on 71,054 different patients.

We identified 356 CVR numbers that were present in both databases. We had no information about the reason for patch-testing of these patients, but the vast majority were most certainly patch-tested as a result of current dermatitis. Thus, cases (n = 356) were defined as patients with dermatitis who had been patch-tested at Gentofte Hospital between 1979 and 2007 and who also had primary THA (and revision) performed between 1996 and 2007 at participating orthopedic departments. Two matched controls (n = 712) from the patch-test database at Gentofte Hospital were sought for each case. Controls were therefore defined as patients suspected of having allergic contact dermatitis who had been patch-tested at Gentofte Hospital between 1979 and 2007, and who were not registered in the DHAR. Matching variables included age and sex. Thus, for each case, two matching controls of the same sex and with the same age in years were found. Matching was not performed according to the year or the outcome of the patch-test.

Patch-testing {#s0004}
-------------

Patch-testing was performed with the European baseline series using Finn chambers (8 mm; Epitest Ltd, Oy, Finland) on Scanpor tape (Norgesplaster A/S, Vennesla, Norway). Nickel sulfate, cobalt chloride, and potassium dichromate were tested in petrolatum in concentrations of 5%, 1%, and 0.5%, respectively, according to international standards. The patch-tests were applied to the upper back and were occluded for 48 h. Readings were done on day 2, day 3 or day 4, and day 7 according to the recommendations from the International Contact Dermatitis Research Group ([@CIT0046]). Thus, homogeneous redness and infiltration in the entire test area was scored as a 1+ reaction. Homogeneous redness, infiltration, and vesicles in the test area were scored as a 2+ reaction, and homogeneous redness, infiltration, and coalescing vesicles in the test area were scored as a 3+ reaction. A 1+, 2+, or 3+ reading was interpreted as a positive response. An irritant response, a doubtful, or a negative reading was interpreted as a negative response.

Statistics {#s0005}
----------

Comparisons between independent variables were made using the chi-square test. Fisher\'s exact test was used when the expected frequency in one of the cells was lower than 5. The statistical significance level was set at 0.05. The prevalence of metal, nickel, chromium, and cobalt allergy in cases and controls was compared using conditional logistic regression analysis to take the matching variables (sex and age) into account. Associations were expressed as odds ratios (ORs) with 95% confidence intervals (CIs). Data were analyzed using SPSS for Windows, release 15.0.

Results {#s0006}
=======

356 patients (defined as cases) were registered in the patch-test database (0.5%) and also in the DHAR. In 64 of the cases (18%), the earliest date was registered in the DHAR (i.e. THA was performed before patch-testing) whereas in 292 cases (82%), the earliest date was registered in the patch-test database (i.e. patch-testing was performed before total hip arthroplasty).

Patient characteristics were generally similar among cases and patients from the DHAR. However, the proportion of female patients was higher among cases (67% versus 58%) ([Table 1](#T0001){ref-type="table"}), which was to be expected as the proportion of women is generally high in Danish patch-test populations ([@CIT0038]). Also, cases belonged more often to the oldest age group (\> 80 years) when compared to patients from the DHAR. This could be attributed to the longer sampling period for dermatitis patients, as the patch database was initiated in 1979 whereas the DHAR only dates from 1996. The prevalence of revision was comparable in cases and patients from the DHAR, as 12% and 13% of patients, respectively, underwent revision between 1996 and 2007 ([Table 1](#T0001){ref-type="table"}). Finally, similar results were found when data were stratified into 3 groups based on the femoral head and acetabular liner materials inserted: (1) "metal-on-metal", (2) "metal-on-polyethylene", and (3) "ceramic-on-ceramic" or "ceramic-on-polyethylene". The high proportion of missing data was explained by insufficient registration of liner materials in the DHAR, as this variable was introduced in recent years.

###### 

Characteristics of patients undergoing primary total hip replacement and revision between 1995 and 2007

  ------------------------------ -------------------------- ------------------------- ----------------- ------------- -------------------- -------
                                 DHAR ^a^(n=70,698) % (n)   Cases ^b^ (n=356) % (n)   OR (95% CI) ^c^   p-value ^c^                        
  Gender                                                                                                                                   
   Female                        58.8                       (41, 136)                 67                \(238\)       0.68 (0.55--0.85)    0.001
  Age-groups                                                                                                                               
   10--49                        5.8                        (4,145)                   1.1               \(4\)         5.45 (2.03--14.61)   0.001
   50--59                        13                         (9,442)                   4.5               \(16\)        3.26 (1.97--5.38)    
   60--69                        28                         (20,060)                  23                \(81\)        1.34 (1.04--1.71)    
   70--79                        35                         (24,821)                  32                \(113\)       1.15 (0.92--1.44)    
   \>80                          18                         (12,586)                  40                \(142\)       0.32 (0.26--0.40)    
  Primary diagnosis                                                                                                                        
   Primary osteoarthritis        76                         (53,944)                  70                \(249\)       1.35 (1.08--1.70)    0.05
   Sequelae of trauma            14                         (10,183)                  19                \(68\)        0.71 (0.54--0.92)    
   Avascular necrosis            2.4                        (1,726)                   3.4               \(12\)        0.71 (0.40--1.27)    
   Rheumatoid arthritis          2.1                        (1,487)                   3.1               \(11\)        0.67 (0.37--1.22)    
   Paediatric conditions         3.4                        (2,385)                   2.5               \(9\)         1.34 (0.69--2.60)    
   Other diagnoses               1.9                        (1,329)                   2.0               \(7\)         0.95 (0.45--2.01)    
  Cause of revision                                                                                                                        
   Aseptic loosening             7.4                        (5,284)                   7.9               \(28\)        0.94 (0.64--1.39)    0.2
   Osteolysis                    0.2                        \(133\)                   0.3               \(1\)         0.67 (0.09--4.77)    
   Deep infection                1.3                        \(908\)                   1.1               \(4\)         1.14 (0.42--3.06)    
   Fracture or luxation          2.8                        (1,986)                   1.1               \(4\)         2.53 (0.94--6.79)    
   Other                         1.3                        \(925\)                   0.6               \(2\)         2.33 (0.58--9.39)    
  Femoral head material                                                                                                                    
   Metal                         76                         (53,618)                  82                \(290\)       0.70 (0.54--0.91)    0.2
   Ceramics                      16                         (11,292)                  13                \(46\)        1.27 (0.93--1.74)    
   Not exchanged (at revision)   0.004                      \(29\)                    0                 --                                 
   Other or missing              8.6                        (6 115)                   5.6               \(20\)        1.58 (1.01--2.49)    
  Acetabular liner material                                                                                                                
   Polyethylene                  40                         (28,425)                  31                \(111\)       1.47 (1.18--1.84)    0.3
   Ceramics                      2.6                        (1,862)                   0.8               \(3\)         3.17 (1.02--9.87)    
   Metal                         1.6                        (1,132)                   1.4               \(5\)         1.14 (0.47--2.75)    
   Other or missing ^d^          56                         (39,635)                  67                \(237\)       0.63 (0.51--0.79)    
  Articulations                                                                                                                            
   Metal-on-polyethylene         28                         (19,933)                  23                \(83\)        1.28 (1.00--1.64)    0.5
   Ceramic-on-ceramic or                                                                                                                   
   ceramic-on-polyethylene       12                         (8,211)                   7.0               \(25\)        1.73 (1.15--2.60)    
   Metal-on-metal                1.1                        \(748\)                   1.1               \(4\)         0.94 (0.35--2.52)    
   Missing ^b^                   59                         (42,161)                  68                \(244\)       0.67 (0.54--0.84)    
  ------------------------------ -------------------------- ------------------------- ----------------- ------------- -------------------- -------

^a^ DHAR: Patients from the Danish Hip Arthroplasty Register (DHAR) 1996--2007.

^b^ Cases, defined as dermatitis patients from the DHAR who were also examined for metal allergy at Gentofte

Hospital.

^c^ Comparison of patients from the Danish Hip Arthroplasty Registry (DHAR) and patients from the DHAR

who were also examined for metal allergy (Chi-square test). Fisher\'s exact test was used when the expected

frequency in one of the cells was lower than 5.

^d^ The proportion of missing data was high, as the variable was introduced in recent years.

OR: odds ratio.

CI: confidence interval.

The prevalence of metal allergy including nickel allergy, cobalt allergy, and chromium allergy was similar among cases and controls ([Table 2](#T0002){ref-type="table"}). When stratified by sex, almost identical trends were identified except for cobalt allergy where the prevalence was 5.9% in female cases and 2.5% in female controls (p = 0.3) (data not shown). The prevalence of metal allergy was similar in cases with and without revision of their arthroplasty ([Table 3](#T0003){ref-type="table"}). The prevalence of metal allergy was lower in 64 cases who were patch-tested after operation than in those who were patch-tested before operation ([Table 4](#T0004){ref-type="table"}). This difference was mainly caused by low prevalences of nickel and cobalt allergy in cases who were patch-tested after their operation. The age distribution in patients who were operated before and after patch-testing was similar. Furthermore, the prevalence of revision was similar in patients who were operated prior to patch-testing and in patients operated after patch-testing.

###### 

The prevalence of metal allergies in cases (n = 356) and matched controls (n = 712) from the patch-test database at Gentofte Hospital, Denmark

  ------------------- ----------------------- -------------------------- -------------
                      Cases (n = 356) % (n)   Controls (n = 712) % (n)   p-value ^a^
  Metal allergy ^b^   14 (51)                 14 (97)                    1.0
  Nickel allergy      10 (36)                 9.8 (70)                   0.8
  Cobalt allergy      5.3 (19)                5.2 (37)                   0.5
  Chromium allergy    3.1 (11)                3.9 (28)                   0.4
  ------------------- ----------------------- -------------------------- -------------

^a^ Comparison of cases and controls matched by sex and by age in

years (conditional logistic regression analysis).

^b^ Metal allergy was defined as a positive patch-test reaction to nickel, cobalt or chromium.

###### 

The prevalence of metal allergies in cases (n = 356) from the patch-test database, stratified by the number of revisions

                      Cases operated once (n = 273) % (n)   Cases revised once (n = 70) % (n)   Cases revised two or three times (n = 13) % (n)   OR (95% CI) ^a^     p-value ^a^
  ------------------- ------------------------------------- ----------------------------------- ------------------------------------------------- ------------------- -------------
  Metal allergy ^b^   16 (43)                               11 (8)                              0                                                 1.38 (0.68--2.80)   0.4
  Nickel allergy      11 (29)                               10 (7)                              0                                                 1.06 (0.48--2.32)   0.9
  Cobalt allergy      5.5 (15)                              5.7 (4)                             0                                                 0.96 (0.32--2.81)   1.0
  Chromium allergy    2.9 (8)                               4.3 (3)                             0                                                 0.68 (0.18--2.51)   0.7

^a^ Comparison of cases without revision and those with one revision (Chi-squared test). Fisher\'s exact test was used when the expected frequency in one of the cells was lower than 5.

^b^ Metal allergy was defined as a positive patch-test reaction to nickel, cobalt, or chromium.

OR: odds ratio.

CI: confidence interval.

###### 

The prevalence of metal allergies and the type of material inserted during hip operation in patients who were patch-tested prior to the operation (n = 292) and in patients who were patch-tested after the operation (n = 64)

                                 Cases patch-tested                                 
  ------------------------------ -------------------- --------- ------------------- -------
  Metal allergy ^b^              16 (47)              6.3 (4)   2.87 (1.00--8.30)   0.4
  Nickel allergy                 11 (33)              4.7 (3)   2.59 (0.77--8.73)   0.1
  Cobalt allergy                 6.5 (19)             0 (0)     --                  0.03
  Chromium allergy               3.1 (9)              3.1 (2)   0.98 (0.21--4.67)   1.0
  Cause of revision                                                                 
   Aseptic loosening             7.5 (22)             9.4 (6)   0.79 (0.31--2.03)   0.2
   Osteolysis                    0                    1.5 (1)   --                  
   Deep infection                1.0 (3)              1.5 (1)   0.65 (0.07--6.39)   
   Fracture or luxation          1.3 (4)              0         --                  
   Other                         0.3 (1)              0         --                  
  Femoral head material                                                             
   Metal                         81 (236)             84 (54)   0.78 (0.37--1.63)   0.6
   Ceramics                      13 (38)              13 (8)    1.05 (0.46--2.37)   
   Not exchanged (at revision)   0                    0         --                  
   Other or missing              6.2 (18)             3.1 (2)   2.04 (0.46-9.01)    
  Acetabular liner material                                                         
   Polyethylene                  35 (103)             13 (8)    3.81 (1.75--8.31)   0.001
   Metal                         1.7 (5)              0         --                  
   Ceramics                      1.0 (3)              0         --                  
   Other or missing              62 (162)             88 (56)   0.18 (0.08--0.39)   

^a^ Comparison of cases and controls (Chi-squared test). Fisher\'s exact test was used when the expected frequency in one of the cells was lower than 5.

^b^ Metal allergy was defined as a positive patch-test reaction to nickel, cobalt or chromium.

OR: odds ratio.

CI: confidence interval.

The use of various commercial femoral head components was investigated (data not shown). Apparently, Lubinus SP II and Taberloc stems were used more frequently in cases than in patients from the DHAR (3% vs. 12% (p \< 0.001) and 9.3% vs. 2.3% (p \< 0.001), respectively) whereas Exeter stems were more prevalent in patients from the DHAR than in cases (18% vs. 4% (p \< 0.001)). Lubinus and Universal Ringlocs were used more frequently as commercial liner components in cases than in patients from the DHAR (33% vs. 11% (p \< 0.001) and 12% vs. 6.1% (p \< 0.001), respectively). No statistically significant differences were identified regarding the use of acetabular liner and femoral head materials between patients tested before and after operation. Also, the prevalence of metal allergy in cases and controls with various commercial femoral head and acetabular liner components was similar to the overall prevalence of metal allergy. Finally, the prevalence of revisions was not associated with any specific components.

Discussion {#s0007}
==========

We found that the use of metal-on-metal prostheses and the prevalence of revisions and its causes following THA was similar in patch-tested dermatitis patients and "ordinary" patients from the DHAR ([Table 1](#T0001){ref-type="table"}). The Department of Dermatology at Gentofte Hospital is a tertiary referral center where patch-testing of patients with moderate-to-severe allergic and eczematous disease is performed. Referred patients generally have increased delayed-type hypersensitivity immune responses upon cutaneous exposure to contact allergens compared to healthy individuals.

Accordingly, the prevalence of metal allergy was markedly higher in cases (and controls) than in subjects from the general population in Denmark ([@CIT0025], [@CIT0041]). Metal allergy typically develops early in life following cutaneous exposure, and is therefore likely to precede THA in most patients ([@CIT0036]). If subjects with metal allergy have an increased risk of complications following THA, e.g. aseptic loosening or reoperations, one would expect the prevalence to be higher in dermatitis patients (who had a high prevalence of metal allergy) than in "ordinary" patients from the DHAR (who were suspected of having a prevalence of metal allergy that was comparable to the prevalence in the general population). However, our study results indicate that dermatitis patients generally do not have an increased risk of complications following THA. The patch-test follow-up period following THA in this study was limited to 1--12 years. Thus, a longer period would possibly have revealed further complications. However, as the year of first operation and the year of patch-testing were equally distributed over the study years among cases, the follow-up time was reasonably long for most patients. Reed et al. published their clinical experience from 22 patients who underwent patch-testing before metal device implantation due to a history of contact allergy ([@CIT0027]). The authors concluded that patch-testing was helpful in guiding the choice of device selected.

A weakness of our study was an insufficient registration regarding various combinations of femoral heads and acetabular liner materials (i.e. "metal-on-metal", "metal-on-polyethylene", and "ceramic-on-ceramic" or "ceramic-on-polyethylene" prostheses) ([Table 1](#T0001){ref-type="table"}). Thus, the study cannot confirm or exclude an association between metal allergy and second generation metal-on-metal prostheses in the entire study material, but only in a sub-sample. It is therefore possible that in patients with missing data (about 60%), an association between second-generation metal-on-metal prostheses and metal allergy, revision, or aseptic loosening might be found. The use of metal femoral stems was significantly higher in cases than in patients from the DHAR (82% vs. 76%). This finding may reflect the fact that ceramic bearings were mainly used in the 1990s and thus that few were present in both databases. Also, it could simply be a result of random error. However, it cannot be completely ruled out that an association exists because of greater metal exposure in patients receiving a metal head than in patients receiving a ceramic head. Our main finding, that metal allergy was not associated with revision or aseptic loosening, was supported by a sub-investigation among cases, which showed that the prevalence of metal allergy was similar in patients who had had no revision performed and in patients who had had one or more revisions ([Table 3](#T0003){ref-type="table"}). However, one should be aware that the study size was small and that a higher number of patients could increase the validity of this finding. Finally, the overall use of various commercial femoral heads and acetabular components was similar in patients from the DHAR and in cases. The prevalence of metal allergy and the proportion of revisions were independent of the commercial subtype of femoral heads and acetabular components.

The prevalence of nickel allergy, cobalt allergy, and chromium allergy was similar in 356 patch-tested dermatitis patients with THA and in 712 patch-tested dermatitis patients without known THA ([Table 2](#T0002){ref-type="table"}). The number of cases was relatively small, which could hide even small differences in the prevalence of metal allergy between cases and controls. However, previous linkage studies with fewer cases have demonstrated inverse associations between contact allergy and prevalent disorders such as diabetes ([@CIT0008]) and inflammatory bowel disease ([@CIT0009]). Furthermore, the prevalence of metal allergy in cases and in controls was similar, and was also the same as that of metal allergies registered in patients from private dermatology practice ([@CIT0042]). Thus, these findings indicate that THA does not lead to higher prevalences of metal allergy. It is interesting that the prevalence of metal allergy (caused by low prevalences of nickel and cobalt allergy) was statistically significantly lower in 64 patients who were patch-tested after total hip arthroplasty than in 292 patients patch-tested before operation. This finding may be the result of random error. Also, the study sample was very small, which reduces validity. However, it is known that tolerance rather than hypersensitivity may develop in some individuals following systemic exposure to an allergen from e.g. dental braces or drinking water ([@CIT0043], [@CIT0032], [@CIT0024]). Whether or not tolerance could explain the difference between the two groups is unknown. We had no knowledge about the indication for patch-testing; however, the vast majority of patients were patch-tested due to dermatitis and not as a result of surgical complications.

We investigated the overall association between contact allergy to selected metals (nickel, cobalt, and chromium) and total hip arthroplasty but were not able to specifically investigate an association with second-generation metal-on-metal prostheses. We found that the risk of surgical revision was not increased in patch-tested dermatitis patients with metal allergies in comparison to "ordinary" THA patients who were not registered in the patch-test database. Also, we found that the prevalence of metal allergy was not increased in patch-tested dermatitis patients who underwent THA in comparison to patch-tested dermatitis patients who were not operated. When interpreting these results, one should bear in mind that the study method had several limitations, such as small sample size and a case-control study design. Furthermore, although the overall prevalence appeared to be similar between the study groups, delayed-type hypersensitivity reactions would undoubtedly develop following exposure to metal implants in a few selected individuals ([@CIT0005], [@CIT0047]). Furthermore, two prospective studies have found an increased incidence of metal allergy in patients with failed implants ([@CIT0013], [@CIT0034]) whereas 2 prospective studies with unselected groups did not find any increase in allergy ([@CIT0006], [@CIT0030]). Despite some important limitations of our study design, our findings add to the evidence that the risk of complications in metal allergic patients appears limited.
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